Literature DB >> 7560855

Androgen receptors in hepatocellular carcinoma and surrounding liver: relationship with tumor size and recurrence rate after surgical resection.

L Boix1, A Castells, J Bruix, M Solé, C Brú, J Fuster, F Rivera, J Rodés.   

Abstract

BACKGROUND/AIMS: This study aimed to evaluate the parameters associated with the presence of androgen receptors in hepatocellular carcinoma and surrounding non-tumoral liver. Furthermore, we have assessed whether androgen receptor positivity influences disease recurrence after surgical resection.
METHODS: Androgen receptor concentration was calculated by receptor binding assay in tumoral and non-tumoral liver in 43 patients (40 of them with cirrhosis) with hepatocellular carcinoma who underwent surgical resection.
RESULTS: Androgen receptors were found in 28 of the tumoral and in 30 of the non-tumoral samples, at concentrations ranging between 5 and 211 fmol/mg protein. The presence of androgen receptors within the tumor was significantly related to a smaller tumor size. Thereby, 22 of the 29 nodules < or = 3 cm contained androgen receptors, while this occurred in only six of the 14 tumors larger than 3 cm (p < 0.05). In contrast, the only parameter associated with the presence of androgen receptors in the non-tumoral liver was a lower gamma-glutamyltranspeptidase concentration. Disease recurrence after surgical resection was not only related to some tumor characteristics (increased alfa-fetoprotein concentration, presence of satellites, differentiation degree), but also to the presence of androgen receptors in the surrounding liver. Thus, the probability of recurrence after 1- and 2-year follow up in patients with androgen-positive livers was 33% and 50%, respectively, while it was 0% and 20% in those with androgen-negative livers (p < 0.05). In contrast, the presence of androgen receptors within the tumor was not associated with a higher recurrence rate.
CONCLUSIONS: These results show that only two thirds of hepatocellular carcinomas contained androgen receptors and that this feature was more frequent in small tumors. In addition, our data indicate that the presence of androgen receptors within the tumor does not imply a different outcome after surgical resection. In contrast, the presence of these receptors in the surrounding non-tumoral liver may be considered a risk factor for a higher incidence of disease recurrence.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7560855     DOI: 10.1016/0168-8278(95)80217-7

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  16 in total

1.  The influence of high serum testosterone levels on the long-term prognosis in male patients undergoing hepatectomy for early stage hepatocellular carcinoma without vascular invasion.

Authors:  Min-Che Lin; Cheng-Chung Wu; Shao-Bin Cheng; Tse-Jia Liu; Fang-Ku P'eng
Journal:  World J Surg       Date:  2007-07       Impact factor: 3.352

Review 2.  Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma.

Authors:  R Tung-Ping Poon; S T Fan; J Wong
Journal:  Ann Surg       Date:  2000-07       Impact factor: 12.969

Review 3.  Role of sex steroid receptors in pathobiology of hepatocellular carcinoma.

Authors:  Mamta Kalra; Jary Mayes; Senait Assefa; Anil-K Kaul; Rashmi Kaul
Journal:  World J Gastroenterol       Date:  2008-10-21       Impact factor: 5.742

4.  Loss of androgen receptor in aging and oxidative stress through Myb protooncoprotein-regulated reciprocal chromatin dynamics of p53 and poly(ADP-ribose) polymerase PARP-1.

Authors:  Liheng Shi; Soyoung Ko; Soyoung Kim; Ibtissam Echchgadda; Tae-Sung Oh; Chung S Song; Bandana Chatterjee
Journal:  J Biol Chem       Date:  2008-10-21       Impact factor: 5.157

5.  Liver expression of steroid hormones and Apolipoprotein D receptors in hepatocellular carcinoma.

Authors:  F J Vizoso; M Rodriguez; A Altadill; M L González-Diéguez; A Linares; L O González; S Junquera; F Fresno-Forcelledo; M D Corte; L Rodrigo
Journal:  World J Gastroenterol       Date:  2007-06-21       Impact factor: 5.742

Review 6.  Androgen receptor signaling in hepatocellular carcinoma and pancreatic cancers.

Authors:  Tatsuo Kanda; Xia Jiang; Osamu Yokosuka
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

7.  A novel small-form NEDD4 regulates cell invasiveness and apoptosis to promote tumor metastasis.

Authors:  Chia-Jung Liao; Hsiang-Cheng Chi; Chung-Ying Tsai; Chi-De Chen; Sheng-Ming Wu; Yi-Hsin Tseng; Yang-Hsiang Lin; I-Hsiao Chung; Ching-Ying Chen; Syuan-Ling Lin; Shiu-Feng Huang; Ya-Hui Huang; Kwang-Huei Lin
Journal:  Oncotarget       Date:  2015-04-20

8.  Testosterone-receptor positive hepatocellular carcinoma in a 29-year old bodybuilder with a history of anabolic androgenic steroid abuse: a case report.

Authors:  Philipp Solbach; Andrej Potthoff; Hans-Jürgen Raatschen; Bisharah Soudah; Ulrich Lehmann; Andrea Schneider; Michael J Gebel; Michael P Manns; Arndt Vogel
Journal:  BMC Gastroenterol       Date:  2015-05-20       Impact factor: 3.067

9.  Impact of sex on the survival of patients with hepatocellular carcinoma: a Surveillance, Epidemiology, and End Results analysis.

Authors:  Dongyun Yang; Diana L Hanna; Josh Usher; Jordan LoCoco; Pritesh Chaudhari; Heinz-Josef Lenz; V Wendy Setiawan; Anthony El-Khoueiry
Journal:  Cancer       Date:  2014-07-31       Impact factor: 6.921

Review 10.  The androgen receptor as an emerging target in hepatocellular carcinoma.

Authors:  Tatsuo Kanda; Osamu Yokosuka
Journal:  J Hepatocell Carcinoma       Date:  2015-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.